The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/406276
LSL LIFESCIENCELEADER.COM NOVEMBER 2014 8 EDITORIAL ADVISORY BOARD EAB ASK THE BOARD Have a response to our experts' answers? Send us an email to atb@lifescienceconnect.com . JOHN BALDONI Chair, Leadership Development Practice, N2growth RAFIK BISHARA, PH.D. Chair, Pharmaceutical Cold Chain Interest Group, PDA WILLIAM CIAMBRONE EVP, Technical Operations, Shire RON COHEN, M.D. President and CEO Acorda Therapeutics, Inc. LAURIE COOKE CEO, Healthcare Businesswomen's Association (HBA) TOM DILENGE General Counsel & Head of Public Policy BIO BARRY EISENSTEIN, M.D. Senior VP, Scientif c Affairs Cubist Pharmaceuticals HEATHER ERICKSON President and CEO Life Sciences Foundation JEFFREY EVANS, PH.D. Life Science Entrepreneur TIM GARNETT CMO, Eli Lilly RON GUIDO President, Lifecare Services, LLC LAURA HALES, PH.D. Founder, The Isis Group ANU HANS VP & CPO Enterprise Supply Chain, J&J; FRED HASSAN Chairman of the Board, Bausch + Lomb JOHN HUBBARD, PH.D. Senior VP & Worldwide Head of Development Operations, Pf zer MAIK JORNITZ Founder, BioProcess Resources, LLC Immediate Past Chair, PDA MITCHELL KATZ, PH.D. Exec. Dir. of Medical Research Operations, Purdue Pharma, L.P. MARY ROSE KELLER Former VP Clinical Operations, Sangart TIMOTHY KRUPA President, TSK Clinical Development JOHN LAMATTINA, PH.D. Senior Partner, PureTech Ventures LYNN JOHNSON LANGER, PH.D. Director, Enterprise and Regulatory Affairs Program Center for Biotechnology Education, Johns Hopkins University CRAIG LIPSET Head of Clinical Innovation, Worldwide Research & Development, Pf zer GREG MACMICHAEL, PH.D. Global Head of Biologics Process R&D; Novartis JEROLD MARTIN Chairman Bio-Process Systems Alliance (BPSA) KENNETH MOCH Former CEO, Chimerix BERNARD MUNOS Founder, InnoThink Center for Research in Biomedical Innovation MIKE MYATT Leadership Advisor, N2growth CAROL NACY, PH.D. CEO, Sequella, Inc. SESHA NEERVANNAN, PH.D. VP Pharmaceutical Development Allergan KEVIN O'DONNELL Senior Partner, Exelsius Cold Chain Mgt. Consultancy U.S., Chair, Int. Air Transport Assoc. Time & Temp. Task Force JOHN ORLOFF, M.D. Head of Global Clinical Development Merck Serono SANDRA POOLE SVP Biologics Operations Industrial Operations, Genzyme, A Sanof Company MARK PYKETT, PH.D. President and CEO Navidea Biopharmaceuticals JOHN REYNDERS, PH.D. Chief Information Off cer Moderna Therapeutics JAMES ROBINSON VP, Vaccine & Biologics Technical Operations, Merck ANDREW SKIBO EVP Operations, MedImmune RVP, AstraZeneca LESLIE WILLIAMS Founder, President, and CEO, ImmusanT What Is The Best Leadership Advice You Ever Received? Q A ONE OF THE MOST USEFUL WAS "… to develop a leadership model that ref ects my values, my leadership philosophy, and my style and then use that model to become a more effective leader." My f rst clinical development manager said such an approach would serve me throughout my career. It took a while to develop that model, and while I continue to tweak it, he was correct. My philosophy is servitude, the leader as a servant. My style is situational, adapting my approach to best affect my team and what it is we are trying to accomplish. As my philosophy and style developed, so did my model of leadership. As my boss and mentor predicted, when my leadership is not having the desired impact, I revisit my model, analyze my actions, and if necessary, adjust. TIM KRUPA Krupa is president of TSK Clinical Development, a consulting f rm providing leadership and solutions in clinical planning, project management, clinical operations, and outsourcing. He began his career with Eli Lilly, and he most recently served as executive director, project management with Quintiles. A I RECEIVED IT FROM KARL BRACHT, former divisional president at Sartorius. His advice was "Treat every person in an organization as important and respectful as any other, no matter what title or status." I believe this not only applies to the business side of life, but also to the personal. An organization is like a clock, every wheel and every part counts, no matter how small or large. If one part does not function, the clock does not work. It is often forgotten that the most valuable asset in a company are the people, all of them, and especially when they work as a team. They must respect, value, and support each other. Only a happy and content organization will supply the best product and services to its customers, and only such a team will go the extra mile for the customer. MAIK JORNITZ Jornitz is COO of G-CON Manufacturing and founder of BioProcess Resources. He has more than 25 years of experience and supports the biopharm industry on a global basis, focusing on validation, optimization, and training in aseptic processing. A "YOU BEHAVE THE SAME WAY whether you are the center of attention or when no one is looking, so you have character — and character counts." This thought was communicated to me in a letter from a former boss, Robert Capizzi, who was CMO and head of R&D; at US Bioscience when I worked there in the early '90s. He spontaneously sent me this note about f ve years after I left the company. Although not directly intended to be leadership advice, it had a profound impact because it made me realize how important authenticity is in a leader and that character is also reputation. As a result, I continuously assess my behavior for consistency and objectivity, and I look for these traits in my colleagues. MARY ROSE KELLER As a former VP of clinical operations, Keller has proven success in planning, management, and delivery of global phase 1 to 4 clinical trials for drug, biologic, and diagnostic products.